 | |
| Names | |
|---|---|
| IUPAC name Methyl 1-[2-(diethylamino)ethyl]-11,17α-dimethoxy-18β-[(3,4,5-trimethoxybenzoyl)oxy]-3β,20α-yohimban-16β-carboxylate | |
| Systematic IUPAC name Methyl (1S,2R,3R,4aS,13bR,14aS)-13-[2-(diethylamino)ethyl]-2,11-dimethoxy-3-[(3,4,5-trimethoxybenzoyl)oxy]-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2′,3′:3,4]pyrido[1,2-b]isoquinoline-1-carboxylate | |
| Identifiers | |
| |
3D model (JSmol) | |
| ChemSpider |
|
| ECHA InfoCard | 100.000.151 |
| UNII | |
| |
| |
| Properties | |
| C39H53N3O9 | |
| Molar mass | 707.865 g·mol−1 |
| Pharmacology | |
| C02AA07 (WHO) | |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Bietaserpine (INN), or1-[2-(diethylamino)ethyl]reserpine, is a derivative ofreserpine used as anantihypertensive agent. Like reserpine, bietaserpine is aVMAT inhibitor.[1]
 | Thisantihypertensive-related article is astub. You can help Wikipedia byexpanding it. |
